Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON

REGULUS THERAPEUTICS INC.

(RGLS)
RiassuntoQuotazioniGraficiNotizieRatingAgendaSocietąFinanzaConsensusRevisioniDerivati 
RiassuntoTutte le notizieRaccomandazione analistiAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settore
Notizie in altre lingue su REGULUS THERAPEUTICS INC.
21/01Health Care Stocks Decline Pre-Bell Friday
21/01Regulus Therapeutics Completes US FDA Meeting for Planned Kidney Disease Trial; Stock U..
20/01Regulus Therapeutics Announces Successful Completion of Pre-IND Meeting with FDA for RG..
20/01Regulus Therapeutics Inc. Announces Successful Completion of Pre-Ind Meeting with FDA f..
05/01REGULUS THERAPEUTICS INC.: Entry into a Material Definitive Agreement, Financial Statemen..
05/01Regulus Therapeutics Inc. Enters into Eleventh Amendment to its Loan and Security Agree..
04/01Regulus Therapeutics to Present at the H.C. Wainwright Virtual BioConnect Conference
2021Regulus Appoints Mohammad Ahmadian, Ph.D., as Vice President, Chemistry and Pharmaceuti..
2021Regulus Therapeutics Announces Presentation at the First Annual Rare & Genetic Kidney D..
2021Regulus Therapeutics Raises $34.6 Million in Common Stock Private Placement
2021REGULUS THERAPEUTICS: SECURITIES PURCHASE AGREEMENT - Form 8-K
2021REGULUS THERAPEUTICS INC.: Other Events, Amendments to Articles of Inc. or Bylaws; Change..
2021Regulus Therapeutics Announces Closing of $34.6 Million Private Placement of Equity
2021REGULUS THERAPEUTICS: Announces Private Placement of Equity - Form 8-K
2021REGULUS THERAPEUTICS INC.: Entry into a Material Definitive Agreement, Unregistered Sale ..
2021Regulus Therapeutics Launches $35 Million Private Placement
2021Regulus Therapeutics Announces Private Placement of Equity
2021REGULUS THERAPEUTICS INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION ..
2021Regulus Therapeutics Reports Third Quarter 2021 Financial Results and Recent Updates - ..
2021REGULUS: Q3 Earnings Snapshot
2021Regulus Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Month..
2021Regulus Therapeutics Announces Timing for Third Quarter 2021 Financial Results Webcast ..
2021REGULUS THERAPEUTICS INC.: Other Events, Financial Statements and Exhibits (form 8-K)
2021AFTER HOURS WATCH LIST SCORECARD: Vst, stim, rgls
2021Health Care Stocks Edging Higher Ahead of Wednesday Close
2021Health Care Stocks Finding Increased Support This Afternoon
2021Wall Street Wavers Pre-Bell as US Consumer Prices Rise More Than Expected, Fed Minutes ..
2021Top Premarket Decliners
2021MT NEWSWIRES AFTER HOURS WATCH LIST: Vst, stim, rgls
2021REGULUS THERAPEUTICS: Shifting Development Focus to Next-Generation Kidney Drug; Stock Pl..
2021REGULUS THERAPEUTICS INC.: Other Events (form 8-K)
2021REGULUS THERAPEUTICS: Announces Strategic Prioritization of RGLS8429, its Next-Generation..
2021Regulus Therapeutics Announces Strategic Prioritization of RGLS8429, its Next-Generatio..
2021REGULUS THERAPEUTICS: to Present at the H.C. Wainwright 23rd Annual Global Investment Con..
2021REGULUS THERAPEUTICS: MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RES..
2021REGULUS: Q2 Earnings Snapshot
2021REGULUS THERAPEUTICS: Reports Second Quarter 2021 Financial Results and Recent Updates (F..
2021REGULUS THERAPEUTICS: Narrows Q2 Loss from Year Ago, Sees Enough Funds Till Q4 Next Year
2021Regulus Therapeutics Inc. Reports Earnings Results for the Second Quarter Ended June 30..
2021REGULUS THERAPEUTICS: Reports Second Quarter 2021 Financial Results and Recent Updates
2021REGULUS THERAPEUTICS: Announces Timing for Second Quarter 2021 Financial Results Webcast ..
2021REGULUS THERAPEUTICS: Presents Additional Data from its Autosomal Dominant Polycystic Kid..
2021Regulus Therapeutics Presents Additional Data from its Autosomal Dominant Polycystic Ki..
2021REGULUS THERAPEUTICS: to Present Additional Data from its Autosomal Dominant Polycystic K..
2021Regulus Therapeutics Inc. to Present Additional Data from Its Autosomal Dominant Polycy..
2021REGULUS THERAPEUTICS: CERTIFICATE OF AMENDMENT OF THE AMENDED AND RESTATED CERTIFICATE OF..
2021REGULUS THERAPEUTICS INC.: Amendments to Articles of Inc. or Bylaws; Change in Fiscal Yea..
2021REGULUS THERAPEUTICS INC.: Other Events, Financial Statements and Exhibits (form 8-K)
2021Regulus Therapeutics Inc. Announces Incremental Update of Autosomal Dominant Polycystic..
2021REGULUS THERAPEUTICS: to Present at the Oppenheimer Rare & Orphan Disease Summit
2021Regulus Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31..
2021REGULUS THERAPEUTICS: MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RES..
2021REGULUS: Q1 Earnings Snapshot
2021REGULUS THERAPEUTICS: Announces Timing for First Quarter 2021 Financial Results Webcast a..
2021REGULUS THERAPEUTICS INC.: Other Events (form 8-K)
2021Regulus Therapeutics Announces Top-Line Data from the First Cohort of Phase 1b Clinical..
2021REGULUS THERAPEUTICS: Completes Dosing in First Cohort of Trial of RGLS4326 to Treat Kidn..
2021REGULUS THERAPEUTICS: Announces Completion of Dosing in the First Cohort of Phase 1b Clin..
2021Regulus Therapeutics Announces Completion of Dosing in the First Cohort of Phase 1b Cli..
2021REGULUS THERAPEUTICS: to Present at the 20th Annual Needham Virtual Healthcare Conference
2021Regulus Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31,..
2021REGULUS: Q4 Earnings Snapshot
2021REGULUS THERAPEUTICS: Q4 Loss Narrows, Revenue Climbs
2021REGULUS THERAPEUTICS: Reports Fourth Quarter and Year-End 2020 Financial Results and Rece..
2021Regulus Therapeutics Inc. Auditor Raises 'Going Concern' Doubt
2021REGULUS THERAPEUTICS: to Present at the H.C. Wainwright Global Life Sciences Conference
2021REGULUS THERAPEUTICS INC.: Entry into a Material Definitive Agreement (form 8-K)
2021REGULUS THERAPEUTICS: Completes Enrollment in First Cohort of Phase 1b Clinical Trial of ..
2021REGULUS THERAPEUTICS: Announces Completion of Enrollment in First Cohort of Phase 1b Clin..
2021Regulus Therapeutics Inc. Announces Completion of Enrollment in First Cohort of Phase 1..
2021REGULUS THERAPEUTICS INC.: Change in Directors or Principal Officers (form 8-K)
2021Regulus Therapeutics Inc. Appoints Alice S. Huang to the Board of Directors
2021REGULUS THERAPEUTICS: to Present at the H.C. Wainwright Virtual BioConnect Conference
2021REGULUS THERAPEUTICS: Files Shelf for Up to 47.4 Million Common Shares on Behalf of Selli..
2020REGULUS THERAPEUTICS: Thinking about buying stock in Inseego Corp, Ampio Pharmaceuticals,..
1  2  3Pross.
Prossimo evento su REGULUS THERAPEUTICS INC.
09/03/22